↓ Skip to main content

Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview

Overview of attention for article published in Frontiers in Pharmacology, August 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
3 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
432 Dimensions

Readers on

mendeley
1271 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview
Published in
Frontiers in Pharmacology, August 2018
DOI 10.3389/fphar.2018.00923
Pubmed ID
Authors

Veronica Salmaso, Stefano Moro

Abstract

Computational techniques have been applied in the drug discovery pipeline since the 1980s. Given the low computational resources of the time, the first molecular modeling strategies relied on a rigid view of the ligand-target binding process. During the years, the evolution of hardware technologies has gradually allowed simulating the dynamic nature of the binding event. In this work, we present an overview of the evolution of structure-based drug discovery techniques in the study of ligand-target recognition phenomenon, going from the static molecular docking toward enhanced molecular dynamics strategies.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,271 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1271 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 195 15%
Student > Bachelor 184 14%
Student > Master 148 12%
Researcher 114 9%
Student > Doctoral Student 43 3%
Other 149 12%
Unknown 438 34%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 232 18%
Chemistry 191 15%
Pharmacology, Toxicology and Pharmaceutical Science 129 10%
Agricultural and Biological Sciences 79 6%
Medicine and Dentistry 24 2%
Other 140 11%
Unknown 476 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2022.
All research outputs
#6,121,640
of 23,053,169 outputs
Outputs from Frontiers in Pharmacology
#2,428
of 16,381 outputs
Outputs of similar age
#106,640
of 333,932 outputs
Outputs of similar age from Frontiers in Pharmacology
#51
of 391 outputs
Altmetric has tracked 23,053,169 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 16,381 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,932 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 391 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.